Lawmakers are once again eyeing drug prices—and this time, the threat to pharma is real: analysts

With the $1.9 trillion American Rescue Plan in the books, congressional lawmakers and White House officials are turning their attention elsewhere. And that could be bad news for drugmakers.

In fact, as the Biden team works through a new, $3 trillion package, lawmakers are looking at targeting drug prices as one component, The Washington Post reports. Under a potential proposal, drugmakers would have to lower certain prices or pay penalties, according to the newspaper.